Journal ArticleOPEN ACCESS

Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis

  • Morishita Y
  • Kusano E
  • Nagata D
The Open Cardiovascular Medicine Journal (2014) 8(1) 6-11
DOI: 10.2174/1874192401408010006
2Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

The renin-angiotensin-aldosterone system (RAAS) blockers have been widely used in chronic kidney disease patients undergoing hemodialysis; however, whether RAAS blockers have beneficial effects for cardiovascular disease in those patients has not been fully defined. This review focuses on the effects of RAAS blockers in chronic kidney disease undergoing hemodialysis for cardiovascular disease.

Cite

CITATION STYLE

APA

Morishita, Y., Kusano, E., & Nagata, D. (2014). Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis. The Open Cardiovascular Medicine Journal, 8(1), 6–11. https://doi.org/10.2174/1874192401408010006

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free